Abstract
The role of oxidative stress has been studied in rheumatoid arthritis (RA) and other inflammatory joint diseases to some extent, but its importance in psoriatic arthritis (PsA) has rarely been investigated. The aim of this study was to analyze the levels of protein oxidation markers, sulfhydryl (SH) and carbonyl (CO) groups, in the synovial fluid (SF) and serum of PsA patients and compare them with the findings in RA and osteoarthritis (OA) patients. A total of 49 subjects with a knee‐joint effusion including 16 PsA, 18 RA, and 15 OA patients were studied. In all patients, the levels of SH groups measured in the serum and SF inversely correlated with the number of white blood cells (WBC) (P<0.05) and the percentage of polymorphonuclear leukocytes (PMN) (P<0.01) in SF. Serum SH levels inversely correlated with serum erythrocyte sedimentation rate (ESR) (P<0.02) and C‐reactive protein (CRP) (P<0.05) values. The SH levels in SF were significantly lower in patients affected by PsA and RA compared to OA cases (P<0.02). The serum SH levels in PsA were lower than OA (P<0.001) and higher than RA patients (P<0.05). The serum and synovial levels of CO groups in PsA, RA, and OA patients were similar. Our study provides novel evidence on the involvement of protein oxidation in PsA and confirms the important role of oxidative stress in the pathogenesis of RA. These data suggest that antioxidant agents can potentially be a useful addition to the conventional therapy in the management of these diseases. J. Clin. Lab. Anal. 22:210–215, 2008. © 2008 Wiley‐Liss, Inc.
Keywords: carbonyl, sulfhydryl, synovial fluid, psoriatic arthritis, oxidative stress
| Abbreviations | |
|---|---|
| CO | carbonyl |
| CRP | C‐reactive protein |
| DNPH | 2,4‐dinitrophenyl hydrazine |
| DTNB | 5,5′‐dithiobis(2‐nitrobenzoic acid) |
| ESR | erythrocyte sedimentation rate |
| OA | osteoarthritis |
| PMN | polymorphonuclear leukocytes |
| PsA | psoriatic arthritis |
| RA | rheumatoid arthritis |
| ROS | reactive oxygen species |
| SF | synovial fluid |
| SH | sulfhydryl |
| WBC | white blood cell. |
REFERENCES
- 1. Betteridge DJ. What is oxidative stress? Metabolism 2000;49:3–8. [DOI] [PubMed] [Google Scholar]
- 2. Hitchon CA, El‐Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265–278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Mantle D, Falkous G, Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45–58. [DOI] [PubMed] [Google Scholar]
- 4. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997;30:351–355. [DOI] [PubMed] [Google Scholar]
- 5. Nourooz‐Zadeh J, Tajaddini‐Sarmadi J, Ling KL, Wolff SP. Low‐density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 1996;313:781–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Jain SK. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 1988;937:205–210. [DOI] [PubMed] [Google Scholar]
- 7. Ozgunes H, Gurer H, Tuncer S. Correlation between serum malondialdehyde and ceruloplasmin activity values in rheumatoid arthritis. Clin Biochem 1995;28:193–194. [DOI] [PubMed] [Google Scholar]
- 8. Selley ML, Bourne DJ, Bartlett MR, et al. Occurrence of (E)‐4‐hydroxy‐2‐nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1992;51:481–484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Basu S, Whiteman M, Mattey DL, Halliwell B. Raised levels of F(2)‐isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 2001;60:627–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kaur H, Halliwell B. Evidence for nitric oxide‐mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9–12. [DOI] [PubMed] [Google Scholar]
- 11. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464–478. [DOI] [PubMed] [Google Scholar]
- 12. Korzon M, Renke J, Popadiuk S, Wozniak M. Carbonyl content in plasma proteins of children with connective tissue inflammatory diseases. Pol J Environ Stud 1998;7:376–377. [Google Scholar]
- 13. Koster JF, Biemond P, Swaak AJ. Intracellular and extracellular sulfhydryl levels in rheumatoid arthritis. Ann Rheum Dis 1986;45:44–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999;19:35–37. [DOI] [PubMed] [Google Scholar]
- 15. Ambanelli U, Spisni A, Ferraccioli GF. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulfhydrylant treatment. Scand J Rheumatol 1982;11:203–207. [DOI] [PubMed] [Google Scholar]
- 16. Wade CR, Jackson PG, Highton J, van Rij AM. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis. Clin Chim Acta 1987;164:245–250. [DOI] [PubMed] [Google Scholar]
- 17. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219–1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Migita K, Yamasaki S, Kita M, et al. Nitric oxide protects cultured rheumatoid synovial cells from Fas‐induced apoptosis by inhibiting caspase‐3. Immunology 2001;103:362–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Chapman ML, Rubin BR, Gracy RW. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1989;16:15–18. [PubMed] [Google Scholar]
- 20. Firuzi O, Fuksa L, Spadaro C, et al. Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 2006;58:951–957. [DOI] [PubMed] [Google Scholar]
- 21. Dougados M, Van Der Linden S, Juhlin R. European Spondyloarthopathy Study Group: The European Spondyloarthopathy Study Group preliminary criteria for the classification of spondyloarthopathy. Arthritis Rheum 1991;34:1218–1227. [DOI] [PubMed] [Google Scholar]
- 22. McGonagle D, Canaghan P, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999;42:1080–1086. [DOI] [PubMed] [Google Scholar]
- 23. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A re‐evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991;30:339–345. [DOI] [PubMed] [Google Scholar]
- 24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324. [DOI] [PubMed] [Google Scholar]
- 25. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380–385. [DOI] [PubMed] [Google Scholar]
- 26. Firuzi O, Giansanti L, Vento R, et al. Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines. J Pharm Pharmacol 2003;55:1021–1027. [DOI] [PubMed] [Google Scholar]
- 27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding. Anal Biochem 1976;72:248–254. [DOI] [PubMed] [Google Scholar]
- 28. Macart M, Gerbaut L. An improvement of the Coomassie Blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid. Clin Chim Acta 1982;122:93–101. [DOI] [PubMed] [Google Scholar]
- 29. Wu SM, Pizzo SV. Alpha(2)‐Macroglobulin from rheumatoid arthritis synovial fluid: functional analysis defines a role for oxidation in inflammation. Arch Biochem Biophys 2001;391:119–126. [DOI] [PubMed] [Google Scholar]
- 30. Pruzanski W, Russell ML, Gordon DA, Ogryzlo MA. Serum and synovial fluid proteins in rheumatoid arthritis and degenerative joint diseases. Am J Med Sci 1973;265:483–490. [DOI] [PubMed] [Google Scholar]